Cargando…
Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients
We would like to comment on the recently published article titled: “Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients” by Ricci et al. The authors grouped the patients into two groups according to the vitamin D levels measured at the time of admission into the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032551/ https://www.ncbi.nlm.nih.gov/pubmed/33832495 http://dx.doi.org/10.1186/s12931-021-01703-1 |
_version_ | 1783676231155187712 |
---|---|
author | Lohia, Prateek Kapur, Shweta Patel, Pragnesh Seyoum, Berhane |
author_facet | Lohia, Prateek Kapur, Shweta Patel, Pragnesh Seyoum, Berhane |
author_sort | Lohia, Prateek |
collection | PubMed |
description | We would like to comment on the recently published article titled: “Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients” by Ricci et al. The authors grouped the patients into two groups according to the vitamin D levels measured at the time of admission into the hospital and reported that lower vitamin D levels are associated with elevated D-dimer and IL-6 levels, low CD4/CD8 ratio and compromised clinical findings with elevated LIPI and SOFA scores. However, review of recent literature shows this association to be debatable. The 25-hydroxyvitamin D levels in the initial phase of critical illness have been reported to drop rapidly and hence consideration of the time of measurement from symptom onset would have enhanced the clinical relevance of these findings. Inferred association between vitamin D levels and disease severity based on SOFA score in COVID-19 patients, needs to be further explored in the light of the recent literature which casts doubt on using SOFA score at admission to predict mortality in COVID-19. |
format | Online Article Text |
id | pubmed-8032551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80325512021-04-09 Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients Lohia, Prateek Kapur, Shweta Patel, Pragnesh Seyoum, Berhane Respir Res Letter to the Editor We would like to comment on the recently published article titled: “Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients” by Ricci et al. The authors grouped the patients into two groups according to the vitamin D levels measured at the time of admission into the hospital and reported that lower vitamin D levels are associated with elevated D-dimer and IL-6 levels, low CD4/CD8 ratio and compromised clinical findings with elevated LIPI and SOFA scores. However, review of recent literature shows this association to be debatable. The 25-hydroxyvitamin D levels in the initial phase of critical illness have been reported to drop rapidly and hence consideration of the time of measurement from symptom onset would have enhanced the clinical relevance of these findings. Inferred association between vitamin D levels and disease severity based on SOFA score in COVID-19 patients, needs to be further explored in the light of the recent literature which casts doubt on using SOFA score at admission to predict mortality in COVID-19. BioMed Central 2021-04-09 2021 /pmc/articles/PMC8032551/ /pubmed/33832495 http://dx.doi.org/10.1186/s12931-021-01703-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Lohia, Prateek Kapur, Shweta Patel, Pragnesh Seyoum, Berhane Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients |
title | Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients |
title_full | Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients |
title_fullStr | Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients |
title_full_unstemmed | Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients |
title_short | Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients |
title_sort | letter to the editor: vitamin d levels in acute illness and clinical severity in covid-19 patients |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032551/ https://www.ncbi.nlm.nih.gov/pubmed/33832495 http://dx.doi.org/10.1186/s12931-021-01703-1 |
work_keys_str_mv | AT lohiaprateek lettertotheeditorvitamindlevelsinacuteillnessandclinicalseverityincovid19patients AT kapurshweta lettertotheeditorvitamindlevelsinacuteillnessandclinicalseverityincovid19patients AT patelpragnesh lettertotheeditorvitamindlevelsinacuteillnessandclinicalseverityincovid19patients AT seyoumberhane lettertotheeditorvitamindlevelsinacuteillnessandclinicalseverityincovid19patients |